{
    "clinical_study": {
        "@rank": "137881", 
        "arm_group": [
            {
                "arm_group_label": "strength training", 
                "arm_group_type": "Experimental", 
                "description": "The subjects will attend for supervised training three sessions per week for 10 weeks (9-12). The strength training program involves dynamic contraction at intensities of 60 - 70 % of 1 repetition maximum (RM) to improve strength and muscle hypertrophy. Each session will contain 8 exercises on the major muscle groups. Each drill consists of 10-12 repetitions (reps) x 3 sets separated by one minute rest between sets."
            }, 
            {
                "arm_group_label": "interval training", 
                "arm_group_type": "Experimental", 
                "description": "High intensity interval training (HIT) three times per week. The three weekly supervised HIT sessions will include two 4x4 min interval sessions and one 10x1 min session. The HIT consist of \"uphill\" treadmill running/walking."
            }, 
            {
                "arm_group_label": "control", 
                "arm_group_type": "No Intervention", 
                "description": "Based on the Norwegian recommendation we will encourage the control group to perform 60 minutes of physical activity at moderate to high intensity on a daily basis."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim is to investigate whether strength training or high intensity interval training is\n      effective in improving insulin sensitivity, cardiovascular outcomes, body composition and\n      reproductive outcomes in women with Polycystic Ovary Syndrome (PCOS).\n\n      Few studies have examined the effect of strength training alone on insulin sensitivity,\n      reproductive outcomes and body composition in women with PCOS. Most previous studies on\n      aerobic exercise in PCOS have applied moderate exercise intensity."
        }, 
        "brief_title": "High Intensity Interval Training or Strength Training in Women With Polycystic Ovary Syndrome", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Polycystic Ovary Syndrome", 
        "condition_browse": {
            "mesh_term": "Polycystic Ovary Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Women\n\n          -  Age 18-45 years old\n\n          -  PCOS\n\n        Exclusion Criteria:\n\n          -  Regular high intensity endurance or strength training (two or more times    per week\n             of vigorous exercise).\n\n          -  Concurrent treatments (insulin sensitizers or drugs known to affect gonadotropin or\n             ovulation, with a wash out period of 1 months prior to inclusion).\n\n          -  On-going pregnancy."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01919281", 
            "org_study_id": "2013/886"
        }, 
        "intervention": [
            {
                "arm_group_label": "strength training", 
                "intervention_name": "strength training", 
                "intervention_type": "Behavioral", 
                "other_name": "resistance training"
            }, 
            {
                "arm_group_label": "interval training", 
                "intervention_name": "interval training", 
                "intervention_type": "Behavioral", 
                "other_name": [
                    "high-intensity exercise", 
                    "aerobic exercise"
                ]
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "exercise", 
            "resistance training", 
            "insulin resistance", 
            "high intensity interval training"
        ], 
        "lastchanged_date": "February 11, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Trondheim", 
                    "country": "Norway", 
                    "zip": "7491"
                }, 
                "name": "Department of circulation and medical imaging , NTNU"
            }
        }, 
        "location_countries": {
            "country": "Norway"
        }, 
        "number_of_arms": "3", 
        "official_title": "High Intensity Interval Training or Strength Training in Women With Polycystic Ovary Syndrome. A Randomized Controlled Trial", 
        "other_outcome": {
            "measure": "Menstruation diary", 
            "safety_issue": "No", 
            "time_frame": "up to 6 months"
        }, 
        "overall_official": {
            "affiliation": "Norwegian University of Science and Technology", 
            "last_name": "Trine Moholdt, phd", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Norway:National Committee for Medical and Health Research Ethics", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "measured with the homeostatic model assessment for insulin resistance (HOMA-IR) method", 
            "measure": "insulin resistance", 
            "safety_issue": "No", 
            "time_frame": "10 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01919281"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measured as body fat % on an impedance scale and waist circumference", 
                "measure": "Body composition", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }, 
            {
                "description": "Measured during maximum effort exercise test", 
                "measure": "Maximum oxygen uptake", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }, 
            {
                "description": "Flow mediated dilatation of the brachial artery.", 
                "measure": "Endothelial function", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }
        ], 
        "source": "Norwegian University of Science and Technology", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Norwegian University of Science and Technology", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}